Shenzhen Bioeasy Biotechnology Co. Ltd. - Asset Resilience Ratio

Latest as of March 2026: 12.61%

Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has an Asset Resilience Ratio of 12.61% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 300942 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥187.64 Million

≈ $27.46 Million USD Cash + Short-term Investments

Total Assets

CN¥1.49 Billion

≈ $217.74 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Shenzhen Bioeasy Biotechnology Co. Ltd.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Shenzhen Bioeasy Biotechnology Co. Ltd. asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen Bioeasy Biotechnology Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does Shenzhen Bioeasy Biotechnology Co. Ltd. carry for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥187.64 Million	12.61%
Total Liquid Assets	CN¥187.64 Million	12.61%

Asset Resilience Insights

Moderate Liquidity: Shenzhen Bioeasy Biotechnology Co. Ltd. has 12.61% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Shenzhen Bioeasy Biotechnology Co. Ltd. Industry Peers by Asset Resilience Ratio

Compare Shenzhen Bioeasy Biotechnology Co. Ltd.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for Shenzhen Bioeasy Biotechnology Co. Ltd. (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Shenzhen Bioeasy Biotechnology Co. Ltd..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	15.43%	CN¥235.30 Million ≈ $34.43 Million	CN¥1.52 Billion ≈ $223.09 Million	-5.35pp
2024-12-31	20.79%	CN¥302.92 Million ≈ $44.33 Million	CN¥1.46 Billion ≈ $213.23 Million	+11.94pp
2023-12-31	8.85%	CN¥120.03 Million ≈ $17.56 Million	CN¥1.36 Billion ≈ $198.48 Million	-20.67pp
2021-12-31	29.52%	CN¥340.21 Million ≈ $49.78 Million	CN¥1.15 Billion ≈ $168.65 Million	+26.29pp
2019-12-31	3.23%	CN¥20.00 Million ≈ $2.93 Million	CN¥619.67 Million ≈ $90.68 Million	--

pp = percentage points

About Shenzhen Bioeasy Biotechnology Co. Ltd.

SHE:300942 China Biotechnology

Market Cap

$380.55 Million

CN¥2.60 Billion CNY

Market Cap Rank

#13779 Global

#4133 in China

Share Price

CN¥6.42

Change (1 day)

+1.90%

52-Week Range

CN¥5.71 - CN¥11.13

All Time High

CN¥40.28